This study highlights the epigenetic disruption of an enhancer targeting TET2, a key regulator of DNA methylomes (Figure 2), as well as dysregulation in enhancers of PD risk genes such as DNAJC6, DCTN1, PRKN, PLA2G6 and FBXO7. Here, PRKN is linked to Parkinson disease.